Concepedia

Ge Yu

GY

Statistics

Publications

8

Citations

313

H-Index

8

Active since

2020

Affiliations

Texas A&M University(Current)

Lawrence Berkeley National Laboratory

Sorrento Therapeutics (United States)

Ge Yu is an author at Texas A&M University specializing in protease inhibitors, drug discovery, and life sciences.

Publications per year

2020–2024

8

Publications

8

MPI8 is Potent against SARS‐CoV‐2 by Inhibiting Dually and Selectively the SARS‐CoV‐2 Main Protease and the Host Cathepsin L**

R. Xinyu, Yugendar R. Alugubelli, Yuying Ma et al. · ChemMedChem · 2021 · 73 citations · Full text

, , +14

A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals

Yugendar R. Alugubelli, Zhi Geng, Kai S. Yang et al. · European Journal of Medicinal Chemistry · 2022 · 52 citations · Full text

, , +16

Expressed Protein Ligation without Intein

Yuchen Qiao, Ge Yu, Kaci C. Kratch et al. · Journal of the American Chemical Society · 2020 · 49 citations · Full text

, , +10

Drug Repurposing for the SARS‐CoV‐2 Papain‐Like Protease

Chia-Chuan D. Cho, Shuhua G. Li, Tyler Lalonde et al. · ChemMedChem · 2021 · 48 citations · Full text

, , +15

A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals

Yuying Ma, Kai S. Yang, Zhi Geng et al. · European Journal of Medicinal Chemistry · 2022 · 42 citations · Full text

, , +15

1–5 of 8